Science
SARS-CoV-2 triggers antibodies from previous coronavirus infections – Drug Target Review
A new study has shown that previous coronavirus infection may contribute to the immune response of patients infected with SARS-CoV-2.
Posted: 22 January 2021 | Victoria Rees (Drug Target Review) | No comments yet
A new study has shown that previous coronavirus infection may contribute to the immune response of patients infected with SARS-CoV-2.
The results of a new study have suggested that the immune systems of people infected with COVID-19 may rely on antibodies created during infections from earlier coronaviruses to help fight the disease.
The study was conducted at Northern Arizona University and the Translational Genomics…
-
Noosa News11 hours agoTeenage girl killed in alleged hit-and-run at Margate north of Brisbane
-
Noosa News9 hours agoTeenage girl dies in hit-and-run, police hunt for ute
-
Noosa News23 hours agoNRL legend Trevor Gillmeister charged with assaulting police officer at Brisbane pub
-
Noosa News24 hours agoSchools ban e-bikes | Noosa Today
